Figure 4

Overall survival curve of patients stratified by MTAP expression. The median OS was 22 months in the MTAP-low group, whereas it was 32 months in the MTAP-high group (p = 0.044). The 1- and 2-year survival were higher in the MTAP-high group (88.8% vs. 79.5%; 67.8% vs. 40.7%, respectively).